Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L B Van

Showing results (191-200 of 437) with videos related to

Pageof 44
Sort By:
Clinical Rheumatology|March 1, 1987
Serum gold concentrations during treatment with auranofinP L Van Riel, F W Gribnau, L B Van de Putte, et al.
Lancet (London, England)|March 3, 1990
Sulphasalazine versus hydroxychloroquine in rheumatoid arthritis: 3-year follow-upD M van der Heijde, P L van Riel, I H Nuver-Zwart, et al.
The Journal of Rheumatology|February 24, 2000
Alternative methods for analysis of radiographic damage in a randomized, double blind, parallel group clinical trial comparing hydroxychloroquine and sulfasalazineD M van der Heijde, P L van Riel, I H Nuver-Zwart, et al.
The American Journal of Pathology|October 1, 1988
Streptococcal cell wall-induced arthritis and flare-up reaction in mice induced by homologous or heterologous cell wallsM F van den Broek, W B van den Berg, L B van de Putte, et al.
Arthritis and Rheumatism|October 3, 2000
The antiinflammatory drug sulfasalazine inhibits tumor necrosis factor alpha expression in macrophages by inducing apoptosisR J Rodenburg, A Ganga, P L van Lent, et al.
Scandinavian Journal of Rheumatology. Supplement|January 1, 1985
Clinical significance of antibodies against nuclear antigens as determined by immunoblottingD J de Rooij, W J Habets, S Stapel, et al.
Clinical and Experimental Immunology|March 1, 1984
Cross-reactivity of anti-DNA antibodies with proteoglycansP Faaber, P J Capel, G P Rijke, et al.
Scandinavian Journal of Immunology|January 1, 1993
Aberrant tolerance induction with cationic antigensM J Jacobs, A E van den Hoek, L B van de Putte, et al.
The Journal of Rheumatology|March 1, 1993
Development of a disease activity score based on judgment in clinical practice by rheumatologistsD M van der Heijde, M van 't Hof, P L van Riel, et al.
Annals of the Rheumatic Diseases|October 1, 1990
Thrombocytopenia due to aurothioglucose, sulphasalazine, and hydroxychloroquineM J Wijnands, W A Allebes, A M Boerbooms, et al.
Pageof 44

Showing results (191-200 of 437) with videos related to

Sort By:
Pageof 44
Clinical Rheumatology|March 1, 1987
Serum gold concentrations during treatment with auranofinP L Van Riel, F W Gribnau, L B Van de Putte, et al.
Lancet (London, England)|March 3, 1990
Sulphasalazine versus hydroxychloroquine in rheumatoid arthritis: 3-year follow-upD M van der Heijde, P L van Riel, I H Nuver-Zwart, et al.
The Journal of Rheumatology|February 24, 2000
Alternative methods for analysis of radiographic damage in a randomized, double blind, parallel group clinical trial comparing hydroxychloroquine and sulfasalazineD M van der Heijde, P L van Riel, I H Nuver-Zwart, et al.
The American Journal of Pathology|October 1, 1988
Streptococcal cell wall-induced arthritis and flare-up reaction in mice induced by homologous or heterologous cell wallsM F van den Broek, W B van den Berg, L B van de Putte, et al.
Arthritis and Rheumatism|October 3, 2000
The antiinflammatory drug sulfasalazine inhibits tumor necrosis factor alpha expression in macrophages by inducing apoptosisR J Rodenburg, A Ganga, P L van Lent, et al.
Scandinavian Journal of Rheumatology. Supplement|January 1, 1985
Clinical significance of antibodies against nuclear antigens as determined by immunoblottingD J de Rooij, W J Habets, S Stapel, et al.
Clinical and Experimental Immunology|March 1, 1984
Cross-reactivity of anti-DNA antibodies with proteoglycansP Faaber, P J Capel, G P Rijke, et al.
Scandinavian Journal of Immunology|January 1, 1993
Aberrant tolerance induction with cationic antigensM J Jacobs, A E van den Hoek, L B van de Putte, et al.
The Journal of Rheumatology|March 1, 1993
Development of a disease activity score based on judgment in clinical practice by rheumatologistsD M van der Heijde, M van 't Hof, P L van Riel, et al.
Annals of the Rheumatic Diseases|October 1, 1990
Thrombocytopenia due to aurothioglucose, sulphasalazine, and hydroxychloroquineM J Wijnands, W A Allebes, A M Boerbooms, et al.
Pageof 44